Health Outcomes Solutions (United States)

Recent papers from Health Outcomes Solutions (United States)

1. Association of diabetes medication adherence quality measure performance with A1c control among Medicare Advantage beneficiariesJournal of Managed Care & Specialty Pharmacy · 2026
2. Relationships between freshwater mussel (Mollusca: Unionida) shell traits, life history strategies and stream size using a large datasetJournal of Natural History · 2026
3. Pacific women’s pre-diagnostic experiences of endometrial cancer across the Auckland region: a qualitative study using talanoaJournal of Primary Health Care · 2026
4. Effectiveness of mepolizumab in patients switching from prior biologic treatments for severe asthma: a post hoc analysis of the NUCALA Effectiveness Study (NEST)Journal of Asthma · 2026
5. An AI-Based Whole-Person Care Summarization Tool for Care Management ProvidersNEJM Catalyst · 2026
6. Clinical and economic impact of bivalent respiratory syncytial virus prefusion F (RSVpreF) vaccination in older adults: a cost-effectiveness analysis for ChileExpert Review of Vaccines · 2026
7. Building recovery capital through an integrated educational and fitness substance use programme: a patient and public involvement (PPI) approachJournal of Integrated Care · 2026
8. Building capacity and advancing collaboration in dissemination and implementation science: insights from a multi-institutional partner networkFrontiers in Health Services · 2026
9. Capturing Family Planning Community Service Data into National Health Management Information Systems: A Five-Country Review of Tools for Community Health Workers and Pharmacies and Drug ShopsGates Open Research · 2026
10. Loneliness, not isolation, is the missing link between social connectedness and mental health among midlife to older U.S. adultsAging & Mental Health · 2026
11. Erythropoietic protoporphyria life impact and genetic health trajectory (LIGHT) study in Europe: a cross-sectional online questionnaireOrphanet Journal of Rare Diseases · 2026
12. Clinical Remission is Achievable for Adult Patients with Severe Asthma Receiving Mepolizumab: A European Retrospective Chart ReviewAdvances in Therapy · 2026
13. Cost-Effectiveness Analysis of Older Adult Vaccination with the Bivalent Respiratory Syncytial Virus Prefusion F (RSVpreF) Vaccine in MexicoVaccines · 2026
14. Changing frequencies: Boston Naming Test normative data for Australian young adultsBrain Impairment · 2026
15. An evaluation of a pilot national online peer support service for kidney disease: feasibility, acceptability and perceived benefitMental Health and Digital Technologies · 2026
16. Costs of Comorbidities and Complications Associated with Type 2 Diabetes: A Retrospective, Cohort StudyAdvances in Therapy · 2026
17. Valbenazine Improves Quality of Life, Functionality, and Movement Severity in Patients With Tardive Dyskinesia: Findings From the KINECT-PRO™ StudyCNS Spectrums · 2026
18. Mepolizumab reduces systemic corticosteroid-related toxicities and healthcare burden in patients with eosinophilic granulomatosis with polyangiitis and hypereosinophilic syndrome: a retrospective database studyFrontiers in Allergy · 2026
19. Defining a Clinically Meaningful Within-Person Change Threshold for the Psychomotor Vigilance Test in Narcolepsy Type 1Therapeutic Innovation & Regulatory Science · 2026
20. Effect of Pre-operative Intravenous Crystalloid Bolus on Post-Induction Blood Pressure – a randomized blinded intervention trialAnesthesiology · 2026